These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24108171)

  • 1. Guidelines for collaboration with industry should be transparent.
    Goldacre B; Carroll D; Hall E
    BMJ; 2013 Oct; 347():f6100. PubMed ID: 24108171
    [No Abstract]   [Full Text] [Related]  

  • 2. The BMJ's stance on collaboration with industry.
    Godlee F
    BMJ; 2013 Oct; 347():f6467. PubMed ID: 24170684
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug companies should release data from all trials of licensed drugs, say MPs.
    Hawkes N
    BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
    [No Abstract]   [Full Text] [Related]  

  • 5. Data sharing will pay dividends.
    Nature; 2014 Jan; 505(7482):131. PubMed ID: 24409508
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical issues at the university-industry interface: a way forward?
    Evans GR; Packham DE
    Sci Eng Ethics; 2003 Jan; 9(1):3-16. PubMed ID: 12645225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 8. Compounding risks to patients: selective disclosure is not an option.
    McGoey L
    Am J Bioeth; 2009 Aug; 9(8):35-6. PubMed ID: 19998156
    [No Abstract]   [Full Text] [Related]  

  • 9. Conflicts of interest of clinicians associated with document on collaboration between doctors and drug industry still being sought.
    Griffith D
    BMJ; 2013 Feb; 346():f1188. PubMed ID: 23444436
    [No Abstract]   [Full Text] [Related]  

  • 10. Falling out with pharma.
    Whitehead S
    Lancet; 2013 Mar; 381(9872):1096-7. PubMed ID: 23540851
    [No Abstract]   [Full Text] [Related]  

  • 11. Doubters ask if IOM report will foster more sharing of clinical trial data.
    Rice S
    Mod Healthc; 2015 Jan; 45(3):10. PubMed ID: 25671895
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Development. Compound interests: how a partnership between academics and a drug company came unstuck.
    Jack A
    BMJ; 2013 Sep; 347():f5356. PubMed ID: 24004997
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems with ethical approval and how to fix them: lessons from three trials in rheumatoid arthritis.
    Mendel J; Goldacre B; Ernst E; Whittle S
    BMJ; 2016 Sep; 354():i4626. PubMed ID: 27613703
    [No Abstract]   [Full Text] [Related]  

  • 14. Partnering between pharma peers on the rise.
    Mullard A
    Nat Rev Drug Discov; 2011 Aug; 10(8):561-2. PubMed ID: 21804581
    [No Abstract]   [Full Text] [Related]  

  • 15. Finer nuances of clinical study agreements for research trials.
    Nayak BK
    Indian J Ophthalmol; 2008; 56(4):267-8. PubMed ID: 18579983
    [No Abstract]   [Full Text] [Related]  

  • 16. Doctors' groups are criticised for endorsing pro-industry guidelines.
    Arie S
    BMJ; 2013 Oct; 347():f6066. PubMed ID: 24107354
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic monoclonal antibodies in the French community: let's get organized].
    Watiez D; Watier H
    Med Sci (Paris); 2009 Dec; 25(12):1189-92. PubMed ID: 20035704
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
    Roehr B
    BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
    [No Abstract]   [Full Text] [Related]  

  • 20. The NCRI cancer experiences collaborative: defining self management.
    Foster C; Brown J; Killen M; Brearley S
    Eur J Oncol Nurs; 2007 Sep; 11(4):295-7. PubMed ID: 17825622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.